![]() |
![]() ![]() |
![]() |
Buy Request | ![]() | Sell Offer | ![]() | Company | ![]() | Reviews | ![]() |
Expire | Country | Pic | Subject | Popularity |
never | ![]() | ![]() | Hepatitis B Virus (HBV) Virus-Like Particles (VLPs) | 157 |
never | ![]() | ![]() | Coxsackievirus A16 (CA16) Virus-Like Particles (VLPs) | 157 |
never | ![]() | ![]() | Virus-Like Particles (VLPs) for Vaccine Development | 157 |
never | ![]() | ![]() | Phosphocholination-Specific Antibody Production Services | 157 |
never | ![]() | ![]() | Diphthamide-Specific Antibody Production Services | 157 |
never | ![]() | ![]() | Carbamylation-Specific Antibody Production Services | 157 |
never | ![]() | ![]() | Glutarylation-Specific Antibody Production Services | 157 |
never | ![]() | ![]() | Protocols | 157 |
never | ![]() | ![]() | Anti-CTLA4 (Ipilimumab)-MC-Vc-PAB-MMAE ADC | 157 |
never | ![]() | ![]() | Anti-CSF2 (Namilumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | 157 |
Copyright © toextrade Inc. All rights reserved. Contact us |